Display options
Share it on

J Health Econ Outcomes Res. 2016 Apr 07;4(1):90-102. doi: 10.36469/9829. eCollection 2016.

Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States.

Journal of health economics and outcomes research

Louise Perrault, Dilip Makhija, Idal Beer, Suzanne Laplante, Sergio Iannazzo, Karthik Raghunathan

Affiliations

  1. International Market Access Consulting, Inc., Zug, Switzerland.
  2. Baxter Healthcare Corporation, Deerfield, IL, USA.
  3. SIHS Health Economics Consulting, Torino, Italy.
  4. Duke University Medical Center, Division of Veterans Affairs, Durham, NC, USA.

PMID: 34414248 PMCID: PMC8341618 DOI: 10.36469/9829

[No abstract available.]

Keywords: cost-effectiveness analysis; crystalloids; electrolytes; intravenous fluid therapy; intravenous rehydration solutions; plasma substitutes

Publication Types